1-6 of 6
Gerard C. Grosveld
Close
Sort by
Journal Articles

Reintroduction of CEBPA in MN1 -overexpressing hematopoietic cells prevents their hyperproliferation and restores myeloid differentiation

Ayten Kandilci, Gerard C. Grosveld
Journal: Blood
Blood (2009) 114 (8): 1596–1606.
https://doi.org/10.1182/blood-2009-02-205443
Published: 2009
Journal Articles

Treating AML with ATRA? Beware MN1 !

Gerard C. Grosveld
Journal: Blood
Blood (2007) 110 (5): 1401–1402.
https://doi.org/10.1182/blood-2007-05-091397
Published: 2007
Journal Articles

The ETS factor TEL2 is a hematopoietic oncoprotein

Cintia Carella, Mark Potter, Jacqueline Bonten, Jerold E. Rehg, Geoffrey Neale, Gerard C. Grosveld
Journal: Blood
Blood (2006) 107 (3): 1124–1132.
https://doi.org/10.1182/blood-2005-03-1196
Published: 2006
Includes: Supplemental data
Journal Articles

Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9

Hiroyuki Kawagoe, Gerard C. Grosveld
Journal: Blood
Blood (2005) 106 (13): 4269–4277.
https://doi.org/10.1182/blood-2005-04-1679
Published: 2005
Includes: Supplemental data
Journal Articles

MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice

Hiroyuki Kawagoe, Gerard C. Grosveld
Journal: Blood
Blood (2005) 106 (13): 4278–4286.
https://doi.org/10.1182/blood-2005-04-1674
Published: 2005
Includes: Supplemental data
Journal Articles

Identification and characterization of a new human ETS-family transcription factor, TEL2 , that is expressed in hematopoietic tissues and can associate with TEL1/ETV6

Mark D. Potter, Arjan Buijs, Brent Kreider, Luc van Rompaey, Gerard C. Grosveld
Journal: Blood
Blood (2000) 95 (11): 3341–3348.
https://doi.org/10.1182/blood.V95.11.3341
Published: 2000